Xiaoxiang Chen
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Variance of HRD From Paired Ovarian Cancer (NCT05069818) | Xiaoxiang Chen | 2021-10-01 |
| Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients (NCT05044091) | Xiaoxiang Chen | 2021-09-15 |
| The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer (NCT04582552) | Xiaoxiang Chen | 2020-12-15 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
Track Xiaoxiang Chen automatically
Every clearance here is in the API, with alerts when new ones post.